Doctor profile · Federal record
Dr. Peeran Sandhu, M.D.
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Salina, KS
- NPI 1003957788
- Accepts Medicare
- MIPS 77.5 / 100 · 2023
- 22 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
511 S Santa Fe Ave, Suite 200
Salina, KS 674014145
(785) 452-4860
fax (785) 452-4878
Credentials & registration
- NPI registered
- February 2007 — 19 yrs on file
- Profile last updated
- May 25, 2015
- Year of graduation
- 2004 — 22 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Kansas #04-35237
- Medicaid
- KS #200739100B
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1003957788. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
112,464
Distinct HCPCS
10
Medicare allowed
$2,893,428
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q5125 |
Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram | 31,200 | 16 | $1 | |
J9271 |
Injection, pembrolizumab, 1 mg | 29,200 | 26 | $54 | |
J9299 |
Injection, nivolumab, 1 mg | 18,980 | 12 | $30 | |
J0897 |
Injection, denosumab, 1 mg | 10,920 | 22 | $23 | |
J9267 |
Injection, paclitaxel, 1 mg | 8,826 | 12 | $0 | |
J9041 |
Injection, bortezomib, 0.1 mg | 2,415 | 12 | $4 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 2,190 | 61 | $0 | |
J1437 |
Injection, ferric derisomaltose, 10 mg | 1,900 | 15 | $20 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,320 | 358 | $121 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 690 | 16 | $1 |
In context: peer comparison
Among 2 peers in Salina Hematology & Oncology Physician, average services per provider: 4,104. This provider delivers 27× the peer median.Open Payments
Industry payments received
All-time total
$593
Transactions
25
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Pfizer INC. | 5 | $89.98 | |
| E.R. Squibb & Sons, L.L.C. | 3 | $51.66 | |
| Merck Sharp & Dohme LLC | 2 | $46.72 | |
| Gilead Sciences, INC. | 2 | $42.92 | |
| Novartis Pharmaceuticals Corporation | 2 | $36.46 | |
| Genentech USA, INC. | 2 | $31.56 | |
| SpringWorks Therapeutics, INC. | 1 | $25.57 | |
| Emd Serono, INC. | 1 | $24.49 | |
| Daiichi Sankyo INC. | 1 | $23.53 | |
| Dendreon Pharmaceuticals LLC | 1 | $22.96 | |
| Takeda Pharmaceuticals U.S.A., INC. | 1 | $22.12 | |
| AstraZeneca Pharmaceuticals Lp | 1 | $20.75 | |
| Janssen Biotech, INC. | 1 | $20.13 | |
| Adc Therapeutics America, INC. | 1 | $19.42 | |
| Kyowa Kirin, INC. | 1 | $19.36 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,016
Patients
203
Total drug cost
$50,476
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 215 | 45 | $2,925 |
| Pantoprazole Sodium | Generic | 138 | 35 | $1,316 |
| Acyclovir | Generic | 113 | 21 | $1,762 |
| Prednisone | Generic | 77 | 26 | $545 |
| Alendronate Sodium | Generic | 66 | 14 | $414 |
| Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim) | Brand | 66 | 15 | $329 |
| Eliquis (Apixaban) | Brand | 62 | 0 | $36,406 |
| Potassium Chloride | Generic | 47 | 16 | $1,712 |
| Gabapentin | Generic | 39 | 0 | $1,126 |
| Furosemide | Generic | 37 | 15 | $182 |
Hospital affiliations
Frequently asked questions
What is Dr. Peeran Sandhu's medical specialty?
Dr. Peeran Sandhu practices Hematology & Oncology Physician in Salina, KS.
Where does Dr. Peeran Sandhu practice?
Dr. Peeran Sandhu practices at 511 S Santa Fe Ave, Salina, KS 674014145. Office phone: 7854524860.
What is Dr. Peeran Sandhu's NPI?
Dr. Peeran Sandhu's National Provider Identifier (NPI) is 1003957788, issued by NPPES.
Does Dr. Peeran Sandhu accept Medicare assignment?
Yes. Dr. Peeran Sandhu accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Peeran Sandhu commonly perform?
Top Medicare-reported procedures in 2023: Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram (HCPCS Q5125); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, nivolumab, 1 mg (HCPCS J9299). Source: CMS Medicare Physician & Other Practitioners file.